Mutant Synuclein Prion Like Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Alpha-synuclein mutations cause familial Parkinson's disease and enable prion-like propagation of pathology. Understanding how mutant synuclein spreads and seeds pathology is crucial for developing disease-modifying therapies.
This page provides comprehensive information about the subject's role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to Alzheimer's disease, Parkinson's disease, and related conditions.
- Synaptic vesicle regulation
- Neurotransmitter release
- Vesicle recycling
- Lipid binding
- A30P: Reduced membrane binding
- E46K: Enhanced aggregation
- A53T: Accelerated fibrilization
- G51D: Altered structure
- Exogenous fibrils as templates
- Endogenous synuclein conversion
- Strain variation
- Template fidelity
- Neuronal uptake
- Axonal transport
- Transsynaptic spread
- Cell-to-cell transmission
- Conformational conversion
- Strain-specific pathology
- Progressive spread
- Long-term persistence
¶ Lewy Body Formation
- Phosphorylated synuclein
- Ubiquitination
- Membrane components
- Multi-protein aggregates
- Synaptic impairment
- Mitochondrial dysfunction
- Axonal transport defects
- ER stress
- Wild-type α-synuclein
- Mutant (A30P, E46K, A53T)
- Human-derived neurons
- Inducible expression
- Preformed fibrils
- Patient-derived seeds
- Brain homogenates
- Synthetic seeds
- Small molecule inhibitors
- Peptide inhibitors
- Antibody fragments
- Natural compounds
- Anti-seed antibodies
- Passive immunotherapy
- Active vaccination
- Peripheral antibodies
- Axonal transport modulators
- Exosome inhibitors
- Cell uptake blockers
- Total α-synuclein
- Phosphorylated α-synuclein
- Oligomeric synuclein
- Seeded aggregation assay
- PET ligands (P2-001, 3-OH-PQ)
- Synaptic imaging
- Neurodegeneration markers
The study of Mutant Synuclein Prion Like Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Spillantini et al., α-Synuclein in Lewy bodies (1997)
- Prusiner et al., Prion-like spreading in PD (2015)
- Luk et al., Exogenous α-synuclein fibrils cause neurodegeneration (2012)
- Volpicelli-Daley et al., Formation of α-synuclein Lewy body-like pathology (2011)